OpenURL Connection Search

Select item for more details and to access through your institution.

Molecular profiling of advanced malignancies guides first-line N-of-1 treatments in the I-PREDICT treatment-naïve study.
Published in:
Genome Medicine, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13073-021-00969-w
By:
- Sicklick, Jason K.;
- Kato, Shumei;
- Okamura, Ryosuke;
- Patel, Hitendra;
- Nikanjam, Mina;
- Fanta, Paul T.;
- Hahn, Michael E.;
- De, Pradip;
- Williams, Casey;
- Guido, Jessica;
- Solomon, Benjamin M.;
- McKay, Rana R.;
- Krie, Amy;
- Boles, Sarah G.;
- Ross, Jeffrey S.;
- Lee, J. Jack;
- Leyland-Jones, Brian;
- Lippman, Scott M.;
- Kurzrock, Razelle
Publication type:
Article
Clinical implications of plasma circulating tumor DNA in gynecologic cancer patients.
Published in:
Molecular Oncology, 2021, v. 15, n. 1, p. 67, doi. 10.1002/1878-0261.12791
By:
- Charo, Lindsey M.;
- Eskander, Ramez N.;
- Okamura, Ryosuke;
- Patel, Sandip P.;
- Nikanjam, Mina;
- Lanman, Richard B.;
- Piccioni, David E.;
- Kato, Shumei;
- McHale, Michael T.;
- Kurzrock, Razelle
Publication type:
Article
Relationship between tumor mutational burden and maximum standardized uptake value in 2-[18F]FDG PET (positron emission tomography) scan in cancer patients.
Published in:
EJNMMI Research, 2020, v. 10, n. 1, p. 1, doi. 10.1186/s13550-020-00732-z
By:
- Haghighat Jahromi, Amin;
- Barkauskas, Donald A.;
- Zabel, Matthew;
- Goodman, Aaron M.;
- Frampton, Garret;
- Nikanjam, Mina;
- Hoh, Carl K.;
- Kurzrock, Razelle
Publication type:
Article
S-warfarin limited sampling strategy with a population pharmacokinetic approach to estimate exposure and cytochrome P450 (CYP) 2C9 activity in healthy adults.
Published in:
European Journal of Clinical Pharmacology, 2021, v. 77, n. 9, p. 1349, doi. 10.1007/s00228-021-03123-y
By:
- Tran, Lana;
- Nikanjam, Mina;
- Capparelli, Edmund V.;
- Bertino Jr, Joseph S.;
- Nafziger, Anne N.;
- Kashuba, Angela D.M.;
- Turpault, Sandrine;
- Ma, Joseph D.
Publication type:
Article
Combination high-dose interleukin-2 and nivolumab for programmed cell death-1 refractory metastatic melanoma: a case series.
Published in:
2022
By:
- Nikanjam, Mina;
- Mullen, Jaren;
- Yacoub, Carol;
- Daniels, Gregory A
Publication type:
journal article
Model Informed Development of VRC01 in Newborn Infants Using a Population Pharmacokinetics Approach.
Published in:
Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 1, p. 184, doi. 10.1002/cpt.2026
By:
- Li, Jerry;
- Nikanjam, Mina;
- Cunningham, Coleen K.;
- McFarland, Elizabeth J.;
- Coates, Emily E.;
- Houser, Katherine V.;
- Lin, Bob C.;
- McDermott, Adrian B.;
- Flach, Britta;
- Gama, Lucio;
- Koup, Richard A.;
- Graham, Barney S.;
- Mascola, John R.;
- Ledgerwood, Julie E.;
- Capparelli, Edmund V.
Publication type:
Article
Population pharmacokinetic analysis of high-dose methotrexate in pediatric and adult oncology patients.
Published in:
2019
By:
- Kawakatsu, Sonoko;
- Nikanjam, Mina;
- Lin, Mark;
- Le, Sonny;
- Saunders, Ila;
- Kuo, Dennis John;
- Capparelli, Edmund V.
Publication type:
journal article
Population pharmacokinetics of siltuximab: impact of disease state.
Published in:
2019
By:
- Nikanjam, Mina;
- Yang, Jin;
- Capparelli, Edmund V.
Publication type:
journal article
Persistent cytarabine and daunorubicin exposure after administration of novel liposomal formulation CPX-351: population pharmacokinetic assessment.
Published in:
2018
By:
- Nikanjam, Mina;
- Capparelli, Edmund V.;
- Lancet, Jeffrey E.;
- Louie, Arthur;
- Schiller, Gary
Publication type:
journal article
Population pharmacokinetic analysis of oxaliplatin in adults and children identifies important covariates for dosing.
Published in:
Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 3, p. 495, doi. 10.1007/s00280-014-2667-6
By:
- Nikanjam, Mina;
- Stewart, Clinton;
- Takimoto, Chris;
- Synold, Timothy;
- Beaty, Orren;
- Fouladi, Maryam;
- Capparelli, Edmund
Publication type:
Article
Relationship between protein biomarkers of chemotherapy response and microsatellite status, tumor mutational burden and PD‐L1 expression in cancer patients.
Published in:
International Journal of Cancer, 2020, v. 146, n. 11, p. 3087, doi. 10.1002/ijc.32661
By:
- Nikanjam, Mina;
- Arguello, David;
- Gatalica, Zoran;
- Swensen, Jeff;
- Barkauskas, Donald A.;
- Kurzrock, Razelle
Publication type:
Article
Dosing targeted and cytotoxic two-drug combinations: Lessons learned from analysis of 24,326 patients reported 2010 through 2013.
Published in:
International Journal of Cancer, 2016, v. 139, n. 9, p. 2135, doi. 10.1002/ijc.30262
By:
- Nikanjam, Mina;
- Liu, Sariah;
- Kurzrock, Razelle
Publication type:
Article
Developmental Pharmacokinetic Changes of Lamivudine in Infants and Children.
Published in:
Journal of Clinical Pharmacology, 2012, v. 52, n. 12, p. 1824, doi. 10.1177/0091270011426563
By:
- Tremoulet, Adriana H.;
- Nikanjam, Mina;
- Cressey, Tim R.;
- Chokephaibulkit, Kulkanya;
- McKinney, Ross;
- Mirochnick, Mark;
- Capparelli, Edmund V.
Publication type:
Article
Transcriptomic analysis of GITR and GITR ligand reveals cancer immune heterogeneity with implications for GITR targeting.
Published in:
American Journal of Cancer Research, 2024, v. 14, n. 4, p. 1634, doi. 10.62347/ECED5481
By:
- Moussa, Peter;
- Kurzrock, Razelle;
- Daisuke Nishizaki;
- Hirotaka Miyashita;
- Lee, Suzanna;
- Nikanjam, Mina;
- Pabla, Sarabjot;
- Nesline, Mary K.;
- Ko, Heidi;
- Conroy, Jeffrey M.;
- DePietro, Paul;
- Sicklick, Jason K.;
- Kato, Shumei
Publication type:
Article
Dosing of 3 Targeted Agents in Novel Drug Combinations Used at the Precision Medicine Clinic of the University of California San Diego.
Published in:
Journal of Hematology Oncology Pharmacy, 2023, v. 13, n. 1, p. 19
By:
- Nikanjam, Mina;
- Tinajero, Jose;
- McGann, Mary;
- Li, Jerry;
- Jincheng Yang;
- Shen, Felicity;
- Sicklick, Jason K.;
- Shumei Kato;
- Capparelli, Edmund;
- Kurzrock, Razelle
Publication type:
Article
ATR inhibition facilitates targeting of leukemia dependence on convergent nucleotide biosynthetic pathways.
Published in:
Nature Communications, 2017, v. 8, n. 1, p. 1, doi. 10.1038/s41467-017-00221-3
By:
- Le, Thuc M.;
- Poddar, Soumya;
- Capri, Joseph R.;
- Abt, Evan R.;
- Woosuk Kim;
- Liu Wei;
- Uong, Nhu T.;
- Cheng, Chloe M.;
- Braas, Daniel;
- Nikanjam, Mina;
- Rix, Peter;
- Merkurjev, Daria;
- Zaretsky, Jesse;
- Kornblum, Harley I.;
- Ribas, Antoni;
- Herschman, Harvey R.;
- Whitelegge, Julian;
- Faull, Kym F.;
- Donahue, Timothy R.;
- Czernin, Johannes
Publication type:
Article
Midazolam Limited Sampling Strategy With a Population Pharmacokinetic Approach to Simultaneously Estimate Cytochrome P450 (CYP) 3A Constitutive, Inhibition, and Induction/Activation Conditions in Healthy Adults.
Published in:
Journal of Clinical Pharmacology, 2019, v. 59, n. 11, p. 1495, doi. 10.1002/jcph.1440
By:
- Yang, Jincheng;
- Nikanjam, Mina;
- Capparelli, Edmund V.;
- Tsunoda, Shirley M.;
- Greenberg, Howard E.;
- Penzak, Scott R.;
- Stoch, S. Aubrey;
- Bertino, Joseph S.;
- Nafziger, Anne N.;
- Ma, Joseph D.
Publication type:
Article
Population Pharmacokinetics of Lopinavir/Ritonavir: Changes Across Formulations and Human Development From Infancy Through Adulthood.
Published in:
Journal of Clinical Pharmacology, 2018, v. 58, n. 12, p. 1604, doi. 10.1002/jcph.1293
By:
- Yang, Jincheng;
- Nikanjam, Mina;
- Best, Brookie M.;
- Pinto, Jorge;
- Chadwick, Ellen G.;
- Daar, Eric S.;
- Havens, Peter L.;
- Rakhmanina, Natella;
- Capparelli, Edmund V.
Publication type:
Article
Midazolam Single Time Point Concentrations to Estimate Exposure and Cytochrome P450 (CYP) 3A Constitutive Activity Utilizing Limited Sampling Strategy With a Population Pharmacokinetic Approach.
Published in:
Journal of Clinical Pharmacology, 2018, v. 58, n. 9, p. 1205, doi. 10.1002/jcph.1125
By:
- Yang, Jincheng;
- Patel, Maulik;
- Nikanjam, Mina;
- Capparelli, Edmund V.;
- Tsunoda, Shirley M.;
- Greenberg, Howard E.;
- Penzak, Scott R.;
- Aubrey Stoch, S.;
- Bertino, Jr., Joseph S.;
- Nafziger, Anne N.;
- Ma, Joseph D.
Publication type:
Article
Dosing Three-Drug Combinations That Include Targeted Anti-Cancer Agents: Analysis of 37,763 Patients.
Published in:
Oncologist, 2017, v. 22, n. 5, p. 576, doi. 10.1634/theoncologist.2016-0357
By:
- Nikanjam, Mina;
- Liu, Sariah;
- Yang, Jincheng;
- Kurzrock, Razelle
Publication type:
Article
Liquid biopsy: current technology and clinical applications.
Published in:
Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01351-y
By:
- Nikanjam, Mina;
- Kato, Shumei;
- Kurzrock, Razelle
Publication type:
Article
Critical insights into the evolving drug‐approval process in China.
Published in:
Cancer (0008543X), 2024, v. 130, n. 5, p. 665, doi. 10.1002/cncr.35186
By:
- Nikanjam, Mina;
- Kurzrock, Razelle
Publication type:
Article
Targeting fusions for improved outcomes in oncology treatment.
Published in:
2020
By:
- Nikanjam, Mina;
- Okamura, Ryosuke;
- Barkauskas, Donald A.;
- Kurzrock, Razelle
Publication type:
journal article
Real-world data from a molecular tumor board demonstrates improved outcomes with a precision N-of-One strategy.
Published in:
Nature Communications, 2020, v. 11, n. 1, p. N.PAG, doi. 10.1038/s41467-020-18613-3
By:
- Kato, Shumei;
- Kim, Ki Hwan;
- Lim, Hyo Jeong;
- Boichard, Amelie;
- Nikanjam, Mina;
- Weihe, Elizabeth;
- Kuo, Dennis J.;
- Eskander, Ramez N.;
- Goodman, Aaron;
- Galanina, Natalie;
- Fanta, Paul T.;
- Schwab, Richard B.;
- Shatsky, Rebecca;
- Plaxe, Steven C.;
- Sharabi, Andrew;
- Stites, Edward;
- Adashek, Jacob J.;
- Okamura, Ryosuke;
- Lee, Suzanna;
- Lippman, Scott M.
Publication type:
Article

Found: 24